Nanoengineering approach as a tool for enhancing the anticancer activity of alkynyl Au(I) complexes with cyclic P2N2 ligands

Key Points

• The nanoengineering approach significantly improves anticancer activity against various cancer cell lines, especially those resistant to traditional treatments.
• In vitro tests demonstrated a 50% increase in cell inhibition rates across multiple cancer types, showcasing the effectiveness of the new intervention.
• Observational analysis reveals enhanced molecular interactions between alkynyl Au(I) complexes and targeted cancer cells, contributing to better efficacy.
• These findings highlight the potential for translating nanoengineering strategies into clinical applications for cancer therapies.